文献速递细胞病理与分子病理胸部病理神经与头颈病理

RNA二代测序在细胞学标本中同步检测肺与甲状腺癌多种基因变异

Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay.
PubMed 文献 · Cancer Cytopathol · 2018-01-24

该研究评估RNA-based二代测序(NGS)在细胞学涂片提取核酸中同步检测单核苷酸变异、插入/缺失和基因融合的可行性。结果显示细胞学与FFPE组织一致率达100%,提示细胞学标本可可靠检测DNA与RNA变异。

要点

  • 细胞学涂片提取核酸可用于RNA-based NGS同步检测多种基因变异。
  • FNA与FFPE组织检测结果一致率达100%。
  • 同步检测多类变异有助于晚期癌症患者靶向治疗评估。

核心结论

  • 细胞学标本可可靠检测DNA和RNA变异,同步检测多种基因变异对晚期癌症患者至关重要,可最大化细胞学标本的效用。

研究设计与样本

  • 共检测27例(17例肺癌、10例甲状腺癌,多数已知变异),从染色涂片刮取感兴趣区域提取总核酸,使用Comprehensive Thyroid and Lung FusionPlex Assay进行基因融合和突变分析。

主要发现

  • 6例检出基因融合。
  • 14例检出EGFR、RAS和BRAF常见单核苷酸变异。
  • 3例检出EGFR框内缺失。
  • FNA与FFPE组织一致率为100%。

临床怎么用

  • FNA来源材料常是唯一可用的病理材料,细胞学涂片可用于同步检测单核苷酸变异、插入/缺失和基因融合,辅助靶向治疗资格评估。
  • 甲状腺结节FNA涂片基因组异常检测可能有助于癌症风险分层并避免二次手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Molecular testing for epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) fusion is routinely performed in patients with stage IV lung adenocarcinoma to assess their eligibility for targeted therapy. Fine-needle aspiration (FNA)-derived material frequently is the only pathologic material available. The identification of genomic aberrations in thyroid nodules from FNA smears may help stratify cancer risk and spare patients from a second surgery. In the current study, the authors tested nucleic acid extracted from the cytology smears of lung and thyroid carcinomas for simultaneous detection of single-nucleotide variant, insertion/deletion, and gene fusion using an RNA-based next-generation sequencing assay. METHODS: A total of 27 cases (17 lung and 10 thyroid carcinomas, the majority of which had known variants) were tested. Areas of interest were scrapped from stained smears using a scalpel. Total nucleic acid was extracted. Gene fusion and mutational analysis was performed using the Comprehensive Thyroid and Lung FusionPlex Assay. Data were analyzed using the analysis pipeline provided by the vendor. Eleven cases with available formalin-fixed, paraffin-embedded (FFPE) tissue were tested in parallel. RESULTS: Gene fusions were detected in 6 cases; common single-nucleotide variants in EGFR, RAS, and BRAF in 14 cases; and in-frame deletions within EGFR in 3 cases. A concordance rate of 100% was observed between FNA and FFPE tissue. CONCLUSIONS: Cytology preparations can be a reliable source for the detection of both DNA and RNA aberrations. The ability to simultaneously detect multiple types of genomic variants is crucial for patients with advanced cancer and maximizes the usefulness of cytology specimens. Cancer Cytopathol 2018;126:158-69. © 2018 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Guseva NV, Jaber O, Stence AA, et al. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay. Cancer Cytopathol. 2018. PMID: 29364576. doi:10.1002/cncy.21963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。